YYC405

· Yooyoung Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YYC405, covering 2022-06-01 to 2022-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients [Phase 3]